- Home
- AXSM vs HHH Comparison
AXSM vs HHH Comparison
Compare AXSM & HHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | HHH |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.1B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | AXSM | HHH |
|---|---|---|
| Price | $149.29 | $85.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 20 | 2 |
| Target Price | ★ $176.00 | $90.00 |
| AVG Volume (30 Days) | ★ 551.7K | 390.5K |
| Earning Date | 11-03-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 234.52 |
| EPS | N/A | ★ 5.10 |
| Revenue | $561,263,000.00 | ★ $1,834,033,000.00 |
| Revenue This Year | $66.20 | N/A |
| Revenue Next Year | $57.56 | $21.07 |
| P/E Ratio | ★ N/A | $16.56 |
| Revenue Growth | 65.83 | ★ 69.81 |
| 52 Week Low | $75.56 | $61.41 |
| 52 Week High | $152.94 | $91.07 |
Technical Indicators
Market Signals| Indicator | AXSM | HHH |
|---|---|---|
| Relative Strength Index (RSI) | 60.77 | 49.95 |
| Support Level | $141.69 | $82.48 |
| Resistance Level | $151.63 | $88.25 |
| Average True Range (ATR) | 4.61 | 2.26 |
| MACD | -0.59 | -0.24 |
| Stochastic Oscillator | 67.13 | 41.70 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About HHH Howard Hughes Holdings Inc.
Howard Hughes Holdings Inc owns, manages, and develops commercial, residential, and mixed-use real estate throughout the USA. Its portfolio is strategically positioned to meet and accelerate development based on market demand, resulting in one of the strongest real estate platforms in the country. It operates through four business segments: Operating Assets, MPCs, Strategic Developments and Seaport.